Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹10.11+0.3% 1 day change | 1.1% | App exclusive | ₹105 Cr |
| AUM (Fund size) | ₹105 Cr |
| Exit load | 0.5% Exit load of 0.50%, if redeemed within 90 days.! |
| Lock-in Period | Nil |
| Age | 11 m since Nov 19, 2024 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹1000 & Lumpsum: ₹5000 |
| Expense ratio | 2.37% as on Sep 30, 2025 |
| Plan type | Regular |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 5.32% | 4.13% |
| 3 Months | 0.1% | -0.51% |
| 6 Months | 5.21% | 6.18% |

Large Cap 45.83%
Mid Cap 18.63%
Small Cap 33.84%
Other Cap 0%
Healthcare 88.82%
Services 4.65%
Insurance 2.53%
Chemicals 2.3%
Bifurcation by Credit Quality is not available for this fund
Others 1.62%
CBLO 1.62%
Net Receivables 0.07999999%
Others 0.08%

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| PGIM India Healthcare Fund | 5.32% | 5.21% | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.05% | 8.15% | 6.14% | 27.48% | 20.98% | 15.16% |
| SBI Healthcare Opportunities Fund | 4.96% | 4.26% | 6.04% | 25.46% | 20.14% | 11.0% |
| DSP Healthcare Fund | 4.04% | 6.64% | -0.97% | 22.43% | 18.11% | 14.77% |
| Tata India Pharma & Healthcare Fund | 3.76% | 5.2% | 1.75% | 22.29% | 18.43% | 11.98% |
| Nippon India Pharma Fund | 3.6% | 3.27% | 1.09% | 21.45% | 18.23% | 12.7% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| PGIM India Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.66 | 0.95 | 1.2 | 1.74 |
| SBI Healthcare Opportunities Fund | 14.07 | 0.84 | 1.19 | 1.86 |
| DSP Healthcare Fund | 14.67 | 0.84 | 1.03 | 1.8 |
| Tata India Pharma & Healthcare Fund | 16.05 | 0.97 | 0.92 | 1.47 |
| Nippon India Pharma Fund | 15.22 | 0.91 | 0.9 | 1.39 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| PGIM India Healthcare Fund | N.A. | 105 Cr | 11 m | 2.37% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,227 Cr | 7 yrs 4 m | 1.87% |
| SBI Healthcare Opportunities Fund | N.A. | 3,933 Cr | 26 yrs 4 m | 1.93% |
| DSP Healthcare Fund | N.A. | 3,074 Cr | 6 yrs 11 m | 1.93% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,296 Cr | 9 yrs 10 m | 2.1% |
| Nippon India Pharma Fund | N.A. | 8,114 Cr | 21 yrs 5 m | 1.82% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 105 Cr as on Sep 30, 2025 |
| Scheme document | View Scheme Document |
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
| No. of schemes | 24 view all schemes |
| Total AUM | 26,927 Cr as on Sep 30, 2025 |
| Address | 7th Floor, Radhe Empire, Chandavarkar Road Borivali (W), Mumbai Mumbai, 400092 |
| Phone | +91 22 6159 5441 / 42 , 1800 209 7446 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| PGIM India ELSS Tax Saver Fund | N.A. | 757 Cr | 6.34% | 19.82% |
| PGIM India Flexi Cap Fund | N.A. | 6,193 Cr | 7.08% | 18.88% |
| PGIM India Large Cap Fund | N.A. | 593 Cr | 6.77% | 15.32% |
| PGIM India Small Cap Fund | N.A. | 1,568 Cr | 5.36% | N.A. |
| PGIM India Global Equity Opportunities FoF | N.A. | 1,615 Cr | 8.54% | 8.65% |
| PGIM India Large and Mid Cap Fund | N.A. | 763 Cr | 8.77% | N.A. |
The current Net Asset Value (NAV) of the PGIM India Healthcare Fund plan is approximately ₹10.11 as of Oct 20, 2025.
The PGIM India Healthcare Fund has an expense ratio of 2.37%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The PGIM India Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 105 Cr as on Sep 30, 2025.
The PGIM India Healthcare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.26% |
| Divi's Laboratories Ltd. | 8.4% |
| Max Healthcare Institute Ltd. | 7.4% |
| Dr. Reddy's Laboratories Ltd. | 6.41% |
| Aster DM Healthcare Ltd. | 6.09% |
| Mankind Pharma Ltd. | 5.22% |
| JB Chemicals & Pharmaceuticals Ltd. | 4.7% |
| Krishna Institute of Medical Sciences Ltd | 3.91% |
| Global Health Ltd. | 3.32% |
| Abbott India Ltd. | 3.32% |
The PGIM India Healthcare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 88.82% |
| Services | 4.65% |
| Insurance | 2.53% |
| Chemicals | 2.3% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the PGIM India Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
